Cargando…

Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity

AIM: Ebselen (Eb) is an example of a repurposed drug with poor aqueous solubility which requires sophisticated delivery system such as nanoencapsulation in nanocapsules for topical application. MATERIALS & METHODS: Eb-nanocapsules were examined for morphology, activity against Candida spp., cyto...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaromin, Anna, Zarnowski, Robert, Piętka-Ottlik, Magdalena, Andes, David R, Gubernator, Jerzy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334256/
https://www.ncbi.nlm.nih.gov/pubmed/29873597
http://dx.doi.org/10.2217/nnm-2017-0337
_version_ 1785070821808537600
author Jaromin, Anna
Zarnowski, Robert
Piętka-Ottlik, Magdalena
Andes, David R
Gubernator, Jerzy
author_facet Jaromin, Anna
Zarnowski, Robert
Piętka-Ottlik, Magdalena
Andes, David R
Gubernator, Jerzy
author_sort Jaromin, Anna
collection PubMed
description AIM: Ebselen (Eb) is an example of a repurposed drug with poor aqueous solubility which requires sophisticated delivery system such as nanoencapsulation in nanocapsules for topical application. MATERIALS & METHODS: Eb-nanocapsules were examined for morphology, activity against Candida spp., cytotoxicity and skin permeation. RESULTS: Eb-nanocapsules were active against skin-infecting Candida tropicalis, Candida albicans and Candida parapsilosis yeasts (minimal inhibitory concentration values were about 4-, 2- and 1.25-times lower vs free Eb, respectively) and able to suppress induced lipid oxidation in the oil/water emulsion. Moreover, demonstrated minimal toxicity in normal human dermal fibroblast cell line, whereas ex vivo skin permeation studies showed no transdermal passage and strong interactions with stratum corneum. CONCLUSION: Eb-nanocapsules represent a promising, safe and complementary alternative to the treatment of cutaneous candidiasis.
format Online
Article
Text
id pubmed-10334256
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-103342562023-07-12 Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity Jaromin, Anna Zarnowski, Robert Piętka-Ottlik, Magdalena Andes, David R Gubernator, Jerzy Nanomedicine (Lond) Research Article AIM: Ebselen (Eb) is an example of a repurposed drug with poor aqueous solubility which requires sophisticated delivery system such as nanoencapsulation in nanocapsules for topical application. MATERIALS & METHODS: Eb-nanocapsules were examined for morphology, activity against Candida spp., cytotoxicity and skin permeation. RESULTS: Eb-nanocapsules were active against skin-infecting Candida tropicalis, Candida albicans and Candida parapsilosis yeasts (minimal inhibitory concentration values were about 4-, 2- and 1.25-times lower vs free Eb, respectively) and able to suppress induced lipid oxidation in the oil/water emulsion. Moreover, demonstrated minimal toxicity in normal human dermal fibroblast cell line, whereas ex vivo skin permeation studies showed no transdermal passage and strong interactions with stratum corneum. CONCLUSION: Eb-nanocapsules represent a promising, safe and complementary alternative to the treatment of cutaneous candidiasis. Future Medicine Ltd 2018-06-06 2018-05 /pmc/articles/PMC10334256/ /pubmed/29873597 http://dx.doi.org/10.2217/nnm-2017-0337 Text en © 2018 Anna Jaromin https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Research Article
Jaromin, Anna
Zarnowski, Robert
Piętka-Ottlik, Magdalena
Andes, David R
Gubernator, Jerzy
Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity
title Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity
title_full Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity
title_fullStr Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity
title_full_unstemmed Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity
title_short Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity
title_sort topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334256/
https://www.ncbi.nlm.nih.gov/pubmed/29873597
http://dx.doi.org/10.2217/nnm-2017-0337
work_keys_str_mv AT jarominanna topicaldeliveryofebselenencapsulatedinbiopolymericnanocapsulesdrugrepurposingenhancedantifungalactivity
AT zarnowskirobert topicaldeliveryofebselenencapsulatedinbiopolymericnanocapsulesdrugrepurposingenhancedantifungalactivity
AT pietkaottlikmagdalena topicaldeliveryofebselenencapsulatedinbiopolymericnanocapsulesdrugrepurposingenhancedantifungalactivity
AT andesdavidr topicaldeliveryofebselenencapsulatedinbiopolymericnanocapsulesdrugrepurposingenhancedantifungalactivity
AT gubernatorjerzy topicaldeliveryofebselenencapsulatedinbiopolymericnanocapsulesdrugrepurposingenhancedantifungalactivity